Skip to main content

Table 1 Characteristics of the samples analyzed in the study

From: Altered expression of mitochondrial and extracellular matrix genes in the heart of human fetuses with chromosome 21 trisomy

Telethon Bank ID

Experiment ID

Karyotype

Age (gw)

PMI (h)

Heart defects

GEO accession

NH GROUP

      

TB 26

H1

46,XY

20

3

NO

GSM30867

TB 21

H2

46,XY

21

3

NO

GSM30868

TB 30

H3

46,XY

20

1

NO

GSM30869

TB 32

H4

46,XX

21

1

NO

GSM30870

TB 23

H5

46,XX

21

4

NO

GSM30871

DSH GROUP

      

TB 37

DH1

47,XY,+21

21

2

NO

GSM30862

TB 43

DH3

47,XY,+21

20

3

NO

GSM30863

TB 50

DH4

47,XY,+21

20

3

NO

GSM30864

TB 47

DH5

47,XY,+21

19

4

NO

GSM30865

TB 48

DH6

47,XY,+21

21

3

NO

GSM30866

TB 9

CDH1

47,XY,+21

22

2

YES

GSM30723

TB 33

CDH2

47,XY,+21

20

4

YES

GSM30855

TB 55

CDH4

47,XX,+21

21

2

YES

GSM30864

TB 22

CDH5

47,XX,+21

18

3

YES

GSM30859

TB 57

CDH6

47,XX,+21

20

3

YES

GSM30860

  1. Experiment accession is GSE1789
  2. DSH = Heart samples from fetuses with trisomy of Hsa21
  3. NH = Heart samples from control fetuses
  4. ID = identifier numbers
  5. gw = gestational weeks
  6. PMI(h) = Post-mortem interval (hours)
  7. Heart defects: TB9, Fallot's trilogy; TB33, Ventricular Septal Defect; TB55 Atrio-Ventricular Canal Defect; TB22 and TB57, Fallot's Tetralogy.
  8. GEO = Gene Expression Omnibus